In the complex landscape of international diplomacy and global public health, few relationships have been as foundational—or...
As the landscape of breast cancer care continues to evolve, the focus for patients is shifting from...
Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...
Disappointing Phase III results for ArriVent BioPharma’s lead candidate, firmonertinib, in the treatment of non-small cell lung...
By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, widely...
HUNTSVILLE, AL — In the rapidly shifting landscape of modern oncology, the distance between a high-tech laboratory...
NEW YORK CITY — On a Tuesday that bridged the gap between the morning commute and a...
OTTAWA – As the landscape of oncology shifts toward increasingly personalized medicine, a comprehensive new national survey...
AMMAN – The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded the...
In a sobering turn of events for the biotechnology sector, Caribou Biosciences—a company anchored by the prestige...
